GlassScriptPhysician profile
Barbara J Morlan
NPI 1740241868
$13,672.02
in general payments reported to CMS, 2019-2025
49 companies · $2,391 in 2025
The $2,391 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,600 · 2020: $1,713 · 2021: $2,498 · 2022: $2,037 · 2023: $1,325 · 2024: $2,108 · 2025: $2,391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,704 · Education: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,703.88 |
| Education | $120.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,068.82 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,072.16 | 2019-2025 | Breztri, Airsupra |
| Amgen INC. | $959.26 | 2019-2025 | Otezla, Repatha, Repatha |
| Lilly USA, LLC | $852.57 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $847.52 | 2019-2025 | Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $764.86 | 2019-2025 | Xifaxan |
| Glaxosmithkline, LLC. | $676.21 | 2019-2025 | Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $666.63 | 2019-2025 | Trintellix |
| Amarin Pharma, INC. | $595.15 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $524.95 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Bayer Healthcare Pharmaceuticals INC. | $493.88 | 2021-2025 | |
| Pfizer INC. | $436.92 | 2019-2025 | |
| Radius Health, INC. | $411.53 | 2020-2025 | Tymlos |
| Otsuka America Pharmaceutical, INC. | $336.49 | 2021-2025 | Rexulti |
| Idorsia Pharmaceuticals US INC | $252.99 | 2022-2024 | Quviviq |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $208.82 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $188.78 | 2019-2025 | Veozah |
| Allergan, INC. | $175.74 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $168.34 | 2021 | |
| Eisai INC. | $167.91 | 2020-2021 | |
| Axsome Therapeutics, INC. | $158.11 | 2023-2024 | Auvelity |
| Abbott Laboratories | $138.64 | 2019-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Lundbeck LLC | $134.90 | 2024-2025 | Rexulti |
| Stryker Corporation | $133.08 | 2025 | Mako |
| Boston Scientific Corporation | $130.63 | 2022 | |
| Arbor Pharmaceuticals, INC. | $118.91 | 2019-2020 | |
| Penumbra, INC. | $109.36 | 2024 | Penumbra System |
| Corium, LLC | $90.60 | 2023 | Azstarys |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $90.36 | 2022-2025 | Caplyta |
| Biohaven Pharmaceutical Holding Company LTD. | $85.85 | 2022 | |
| Merck Sharp & Dohme LLC | $85.54 | 2020-2024 | |
| Kowa Pharmaceuticals America, INC. | $64.38 | 2023-2025 | Zoryve, Seglentis |
| Lupin INC. | $53.75 | 2020 | |
| Novartis Pharmaceuticals Corporation | $45.51 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $41.94 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $37.75 | 2024-2025 | Voquezna |
| Ironwood Pharmaceuticals, INC | $36.52 | 2021-2022 | |
| Sanofi Pasteur INC. | $35.05 | 2023-2024 | |
| Shire North American Group INC | $28.65 | 2019 | |
| Coloplast Corp | $25.62 | 2022 | |
| Agios Pharmaceuticals, INC. | $25.56 | 2025 | Pyrukynd |
| Esperion Therapeutics, INC. | $21.13 | 2023 | Nexletol |
| Becton, Dickinson and Company | $20.46 | 2025 | Rotarexs 6 F X 135 Cm |
| Ardelyx, INC. | $16.90 | 2024 | Ibsrela |
| Hologic Sales and Service, LLC | $16.70 | 2019 | |
| Nabriva Therapeutics, Plc | $15.28 | 2020 | |
| Tolmar, INC. | $14.51 | 2025 | Jatenzo |
| Genentech USA, INC. | $13.42 | 2021 | |
| Horizon Therapeutics Plc | $13.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Morlan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.